A citation-based method for searching scientific literature

J Alexander Bodkin, Michael J Coleman, Laura J Godfrey, Claudia M B Carvalho, Charity J Morgan, Raymond F Suckow, Thea Anderson, Dost Öngür, Marc J Kaufman, Kathryn E Lewandowski, Arthur J Siegel, Elliot Waldstreicher, Christopher M Grochowski, Daniel C Javitt, Dan Rujescu, Scott Hebbring, Richard Weinshilboum, Stephanie Burgos Rodriguez, Colette Kirchhoff, Timothy Visscher, Alexander Vuckovic, Allison Fialkowski, Shane McCarthy, Dheeraj Malhotra, Jonathan Sebat, Donald C Goff, James I Hudson, James R Lupski, Joseph T Coyle, Uwe Rudolph, Deborah L Levy. Biol Psychiatry 2019
Times Cited: 15







List of co-cited articles
114 articles co-cited >1



Times Cited
  Times     Co-cited
Similarity


Contribution of copy number variants to schizophrenia from a genome-wide study of 41,321 subjects.
Christian R Marshall, Daniel P Howrigan, Daniele Merico, Bhooma Thiruvahindrapuram, Wenting Wu, Douglas S Greer, Danny Antaki, Aniket Shetty, Peter A Holmans, Dalila Pinto,[...]. Nat Genet 2017
398
33


A large data resource of genomic copy number variation across neurodevelopmental disorders.
Mehdi Zarrei, Christie L Burton, Worrawat Engchuan, Edwin J Young, Edward J Higginbotham, Jeffrey R MacDonald, Brett Trost, Ada J S Chan, Susan Walker, Sylvia Lamoureux,[...]. NPJ Genom Med 2019
31
20

Analysis of Intellectual Disability Copy Number Variants for Association With Schizophrenia.
Elliott Rees, Kimberley Kendall, Antonio F Pardiñas, Sophie E Legge, Andrew Pocklington, Valentina Escott-Price, James H MacCabe, David A Collier, Peter Holmans, Michael C O'Donovan,[...]. JAMA Psychiatry 2016
53
20

CNVs conferring risk of autism or schizophrenia affect cognition in controls.
Hreinn Stefansson, Andreas Meyer-Lindenberg, Stacy Steinberg, Brynja Magnusdottir, Katrin Morgen, Sunna Arnarsdottir, Gyda Bjornsdottir, G Bragi Walters, Gudrun A Jonsdottir, Orla M Doyle,[...]. Nature 2014
371
20

High-resolution copy number variation analysis of schizophrenia in Japan.
I Kushima, B Aleksic, M Nakatochi, T Shimamura, T Shiino, A Yoshimi, H Kimura, Y Takasaki, C Wang, J Xing,[...]. Mol Psychiatry 2017
54
20

Enhanced astrocytic d-serine underlies synaptic damage after traumatic brain injury.
Enmanuel J Perez, Stephen A Tapanes, Zachary B Loris, Darrick T Balu, Thomas J Sick, Joseph T Coyle, Daniel J Liebl. J Clin Invest 2017
46
20

Synaptic and extrasynaptic NMDA receptors are gated by different endogenous coagonists.
Thomas Papouin, Laurent Ladépêche, Jérôme Ruel, Silvia Sacchi, Marilyne Labasque, Marwa Hanini, Laurent Groc, Loredano Pollegioni, Jean-Pierre Mothet, Stéphane H R Oliet. Cell 2012
417
20

Modulation of N-methyl-D-aspartate receptor function by glycine transport.
R Bergeron, T M Meyer, J T Coyle, R W Greene. Proc Natl Acad Sci U S A 1998
335
20

D-serine added to antipsychotics for the treatment of schizophrenia.
G Tsai, P Yang, L C Chung, N Lange, J T Coyle. Biol Psychiatry 1998
493
20

Identity of the NMDA receptor coagonist is synapse specific and developmentally regulated in the hippocampus.
Matildé Le Bail, Magalie Martineau, Silvia Sacchi, Natalia Yatsenko, Inna Radzishevsky, Sandrine Conrod, Karima Ait Ouares, Herman Wolosker, Loredano Pollegioni, Jean-Marie Billard,[...]. Proc Natl Acad Sci U S A 2015
68
20

Identity of endogenous NMDAR glycine site agonist in amygdala is determined by synaptic activity level.
Yan Li, Silvia Sacchi, Loredano Pollegioni, Alo C Basu, Joseph T Coyle, Vadim Y Bolshakov. Nat Commun 2013
55
20


Multiple risk pathways for schizophrenia converge in serine racemase knockout mice, a mouse model of NMDA receptor hypofunction.
Darrick T Balu, Yan Li, Matthew D Puhl, Michael A Benneyworth, Alo C Basu, Shunsuke Takagi, Vadim Y Bolshakov, Joseph T Coyle. Proc Natl Acad Sci U S A 2013
128
20

Serine racemase deletion disrupts memory for order and alters cortical dendritic morphology.
L M DeVito, D T Balu, B R Kanter, C Lykken, A C Basu, J T Coyle, H Eichenbaum. Genes Brain Behav 2011
83
20

The Rise and Fall of the d-Serine-Mediated Gliotransmission Hypothesis.
Herman Wolosker, Darrick T Balu, Joseph T Coyle. Trends Neurosci 2016
93
20

The NMDA receptor co-agonists, D-serine and glycine, regulate neuronal dendritic architecture in the somatosensory cortex.
Darrick T Balu, Alo C Basu, John P Corradi, Angela M Cacace, Joseph T Coyle. Neurobiol Dis 2012
59
20

Serine Racemase and D-serine in the Amygdala Are Dynamically Involved in Fear Learning.
Darrick T Balu, Kendall Taylor Presti, Cathy C Y Huang, Kevin Muszynski, Inna Radzishevsky, Herman Wolosker, Guia Guffanti, Kerry J Ressler, Joseph T Coyle. Biol Psychiatry 2018
14
21

Targeted disruption of serine racemase affects glutamatergic neurotransmission and behavior.
A C Basu, G E Tsai, C-L Ma, J T Ehmsen, A K Mustafa, L Han, Z I Jiang, M A Benneyworth, M P Froimowitz, N Lange,[...]. Mol Psychiatry 2009
201
20

Identification of Neuropsychiatric Copy Number Variants in a Health Care System Population.
Christa Lese Martin, Karen E Wain, Matthew T Oetjens, Kasia Tolwinski, Emily Palen, Abby Hare-Harris, Lukas Habegger, Evan K Maxwell, Jeffrey G Reid, Lauren Kasparson Walsh,[...]. JAMA Psychiatry 2020
11
27

Joint Contributions of Rare Copy Number Variants and Common SNPs to Risk for Schizophrenia.
Sarah E Bergen, Alexander Ploner, Daniel Howrigan, Michael C O'Donovan, Jordan W Smoller, Patrick F Sullivan, Jonathan Sebat, Benjamin Neale, Kenneth S Kendler. Am J Psychiatry 2019
41
20

Reduced D-serine to total serine ratio in the cerebrospinal fluid of drug naive schizophrenic patients.
Kenji Hashimoto, Göran Engberg, Eiji Shimizu, Conny Nordin, Leif H Lindström, Masaomi Iyo. Prog Neuropsychopharmacol Biol Psychiatry 2005
189
13

Is D-cycloserine a prodrug for D-serine in the brain?
Mao Horio, Hisashi Mori, Kenji Hashimoto. Biol Psychiatry 2013
13
15

Decreased serum levels of D-serine in patients with schizophrenia: evidence in support of the N-methyl-D-aspartate receptor hypofunction hypothesis of schizophrenia.
Kenji Hashimoto, Takeshi Fukushima, Eiji Shimizu, Naoya Komatsu, Hiroyuki Watanabe, Naoyuki Shinoda, Michiko Nakazato, Chikara Kumakiri, Shin-ichi Okada, Hisanori Hasegawa,[...]. Arch Gen Psychiatry 2003
367
13

Targeting of NMDA receptors in new treatments for schizophrenia.
Kenji Hashimoto. Expert Opin Ther Targets 2014
83
13

Developmental Delay, Treatment-Resistant Psychosis, and Early-Onset Dementia in a Man With 22q11 Deletion Syndrome and Huntington's Disease.
Martilias Farrell, Maya Lichtenstein, James J Crowley, Dawn M Filmyer, Gabriel Lázaro-Muñoz, Rita A Shaughnessy, Ian R Mackenzie, Veronica Hirsch-Reinshagen, Robert Stowe, James P Evans,[...]. Am J Psychiatry 2018
6
33

The penetrance of copy number variations for schizophrenia and developmental delay.
George Kirov, Elliott Rees, James T R Walters, Valentina Escott-Price, Lyudmila Georgieva, Alexander L Richards, Kimberly D Chambert, Gerwyn Davies, Sophie E Legge, Jennifer L Moran,[...]. Biol Psychiatry 2014
194
13

Developmental brain dysfunction: revival and expansion of old concepts based on new genetic evidence.
Andres Moreno-De-Luca, Scott M Myers, Thomas D Challman, Daniel Moreno-De-Luca, David W Evans, David H Ledbetter. Lancet Neurol 2013
169
13



Phenotypic heterogeneity of genomic disorders and rare copy-number variants.
Santhosh Girirajan, Jill A Rosenfeld, Bradley P Coe, Sumit Parikh, Neil Friedman, Amy Goldstein, Robyn A Filipink, Juliann S McConnell, Brad Angle, Wendy S Meschino,[...]. N Engl J Med 2012
353
13

Copy Number Variation in Syndromic Forms of Psychiatric Illness: The Emerging Value of Clinical Genetic Testing in Psychiatry.
Christian G Bouwkamp, Anneke J A Kievit, Sander Markx, Joseph I Friedman, Laura van Zutven, Rick van Minkelen, Terry Vrijenhoek, Bin Xu, Ineke Sterrenburg-van de Nieuwegiessen, Joris A Veltman,[...]. Am J Psychiatry 2017
9
22

Large-scale copy number polymorphism in the human genome.
Jonathan Sebat, B Lakshmi, Jennifer Troge, Joan Alexander, Janet Young, Pär Lundin, Susanne Månér, Hillary Massa, Megan Walker, Maoyen Chi,[...]. Science 2004
13


What Should a Psychiatrist Know About Genetics? Review and Recommendations From the Residency Education Committee of the International Society of Psychiatric Genetics.
John I Nurnberger, Jehannine Austin, Wade H Berrettini, Aaron D Besterman, Lynn E DeLisi, Dorothy E Grice, James L Kennedy, Daniel Moreno-De-Luca, James B Potash, David A Ross,[...]. J Clin Psychiatry 2018
17
13

Psychiatric disorders from childhood to adulthood in 22q11.2 deletion syndrome: results from the International Consortium on Brain and Behavior in 22q11.2 Deletion Syndrome.
Maude Schneider, Martin Debbané, Anne S Bassett, Eva W C Chow, Wai Lun Alan Fung, Marianne van den Bree, Michael Owen, Kieran C Murphy, Maria Niarchou, Wendy R Kates,[...]. Am J Psychiatry 2014
386
13

Medical consequences of pathogenic CNVs in adults: analysis of the UK Biobank.
Karen Crawford, Matthew Bracher-Smith, David Owen, Kimberley M Kendall, Elliott Rees, Antonio F Pardiñas, Mark Einon, Valentina Escott-Price, James T R Walters, Michael C O'Donovan,[...]. J Med Genet 2019
38
13


High dose D-serine in the treatment of schizophrenia.
Joshua T Kantrowitz, Anil K Malhotra, Barbara Cornblatt, Gail Silipo, Andrea Balla, Raymond F Suckow, Cyril D'Souza, John Saksa, Scott W Woods, Daniel C Javitt. Schizophr Res 2010
152
13

The NMDA receptor as a target for cognitive enhancement.
Graham L Collingridge, Arturas Volianskis, Neil Bannister, Grace France, Lydia Hanna, Marion Mercier, Patrick Tidball, Guangyu Fang, Mark W Irvine, Blaise M Costa,[...]. Neuropharmacology 2013
151
13

Sarcosine or D-serine add-on treatment for acute exacerbation of schizophrenia: a randomized, double-blind, placebo-controlled study.
Hsien-Yuan Lane, Yue-Cune Chang, Yi-Ching Liu, Chih-Chiang Chiu, Guochuan E Tsai. Arch Gen Psychiatry 2005
206
13

A multicenter, add-on randomized controlled trial of low-dose d-serine for negative and cognitive symptoms of schizophrenia.
Mark Weiser, Uriel Heresco-Levy, Michael Davidson, Daniel C Javitt, Nomi Werbeloff, Ari A Gershon, Yehuda Abramovich, Daniela Amital, Adiel Doron, Shai Konas,[...]. J Clin Psychiatry 2012
63
13

Altering the course of schizophrenia: progress and perspectives.
Mark J Millan, Annie Andrieux, George Bartzokis, Kristin Cadenhead, Paola Dazzan, Paolo Fusar-Poli, Jürgen Gallinat, Jay Giedd, Dennis R Grayson, Markus Heinrichs,[...]. Nat Rev Drug Discov 2016
232
13

D-serine is an endogenous ligand for the glycine site of the N-methyl-D-aspartate receptor.
J P Mothet, A T Parent, H Wolosker, R O Brady, D J Linden, C D Ferris, M A Rogawski, S H Snyder. Proc Natl Acad Sci U S A 2000
818
13


Asc-1 Transporter Regulation of Synaptic Activity via the Tonic Release of d-Serine in the Forebrain.
Hagit Sason, Jean Marie Billard, Garrick Paul Smith, Hazem Safory, Samah Neame, Eitan Kaplan, Dina Rosenberg, Salman Zubedat, Veronika N Foltyn, Claus Tornby Christoffersen,[...]. Cereb Cortex 2017
37
13

Postnatal NMDA receptor ablation in corticolimbic interneurons confers schizophrenia-like phenotypes.
Juan E Belforte, Veronika Zsiros, Elyse R Sklar, Zhihong Jiang, Gu Yu, Yuqing Li, Elizabeth M Quinlan, Kazu Nakazawa. Nat Neurosci 2010
519
13

Neuronal D-serine and glycine release via the Asc-1 transporter regulates NMDA receptor-dependent synaptic activity.
Dina Rosenberg, Samar Artoul, Adi C Segal, Goren Kolodney, Inna Radzishevsky, Elena Dikopoltsev, Veronika N Foltyn, Ran Inoue, Hisashi Mori, Jean-Marie Billard,[...]. J Neurosci 2013
132
13

A randomized, double-blind, placebo-controlled comparison study of sarcosine (N-methylglycine) and D-serine add-on treatment for schizophrenia.
Hsien-Yuan Lane, Ching-Hua Lin, Yu-Jhen Huang, Chun-Hui Liao, Yue-Cune Chang, Guochuan E Tsai. Int J Neuropsychopharmacol 2010
121
13



Co-cited is the co-citation frequency, indicating how many articles cite the article together with the query article. Similarity is the co-citation as percentage of the times cited of the query article or the article in the search results, whichever is the lowest. These numbers are calculated for the last 100 citations when articles are cited more than 100 times.